Close
American Drug Delivery & Formulation Summit
Xylem

News

US to invest $472 million more in Moderna to speed up vaccine process

Moderna has unveiled a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) for an additional commitment of up to $472 million to support late stage clinical development including the expanded Phase 3 study of...

LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma

LGM Pharma announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. The combination brings together LGM Pharmaโ€™s global leadership in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management...

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

Samsung Biologics (207940.KS) announced a plan to expand its Drug Product (DP) capability in line with increasing market demand and to ensure flexible production capabilities for new and existing clients. Samsung Biologics has been providing aseptic filling and lyophilization services...

LabCorps drug development business, Covance Acquired of GlobalCare Clinical Trials, LLC

LabCorpโ€™s drug development business, Covance, has acquired GlobalCare, a provider of patient-centric decentralized clinical trials support services. This acquisition will expand Covanceโ€™s decentralized clinical trials capabilities globally, enabling recruitment and increasing access to trials. Covance will leverage GlobalCareโ€™s mobile healthcare...

Avid Bioservices, Argonaut Enter Manufacturing Services Pact

Avid Bioservices, Inc., a biologics CDMO, and Argonaut Manufacturing Services, a cGMP contract manufacturing organization (CMO) have entered a co-marketing agreement to provide an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing. The companies...

Abzena receives growth capital investment from newly launched Biospring Partners

Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm. The new capital...

CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched

CPhI Japan organised by Informa Markets announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until *April 14-16, 2021. The event organiserโ€™s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป